Related Articles
Investigation of EGFR mutations in non‑small cell lung cancer usually undetectable by PCR methods
EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature
Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer
Concurrent TP53 mutations predict a poor prognosis of EGFR‑mutant NSCLCs treated with TKIs: An updated systematic review and meta‑analysis
Epidermal growth factor receptor somatic mutation analysis in 354 Chinese patients with non-small cell lung cancer